GREVIT: A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo (clinicaltrials.gov) - Jun 15, 2026 - P1/2 | N=116 | Not yet recruiting | Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
New P1/2 trial • Dermatology • Immunology • Vitiligo
|